GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Research & Development

Imricor Medical Systems (ASX:IMR) Research & Development : A$11.82 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Imricor Medical Systems's Research & Development for the six months ended in Dec. 2023 was A$5.98 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$11.82 Mil.

Imricor Medical Systems Research & Development Historical Data

The historical data trend for Imricor Medical Systems's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Research & Development Chart

Imricor Medical Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 5.23 7.37 13.53 11.78 11.83

Imricor Medical Systems Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only 6.99 6.35 5.16 5.84 5.98

Imricor Medical Systems Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$11.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imricor Medical Systems  (ASX:IMR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Imricor Medical Systems Research & Development Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems (ASX:IMR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Research & Development
Comparable Companies
ASX:EMV ASX:MX1 ASX:SOM ASX:UBI ASX:NTI ASX:4DX ASX:EYE ASX:RSH ASX:CYC ASX:CMP ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
400 Gateway Boulevard, Burnsville, MN, USA, 55337
Website
https://www.imricor.com
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines